RESULTS	PIO 30 treated patients had similar increase in plasma 15-epi-LXA ( 4 ) ( 0.64 0.10-1 .08 0.09 ng/mL , p < 0.01 ) , and decrease in plasma FFA ( 423 42-317 40 mol/l , p < 0.05 ) despite a greater increase in plasma adiponectin ( 6.5 0.4-15 .5 0.7 ug/mL , p < 0.001 ) and a greater reduction in HbA1c ( 8.7 0.5-7 .4 0.3 % , p < 0.01 ) , FPG ( 159 16-120 10 mg/dL , p < 0.01 ) , and HOMA-IR ( 6.6 0.8-4 .4 0.4 , p < 0.005 ) .\